Business
Junior biotech’s shares jump 10% on good news out of the US
Image source: Getty Images
Neurizon Therapeutics Ltd (ASX: NUZ) shares are up more than 10% in early trade after the company said there had been a key development in the US for its lead investigational drug, NUZ-001.
The company stated that the US Food and Drug Administration (FDA) had lifted…
Continue Reading
-
Noosa News20 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News20 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
Noosa News22 hours agoQueensland’s domestic violence policing and policies are being shaped by lived experience
-
Noosa News12 hours agoQueensland’s ‘promising’ coercive control laws see more than 50 charges laid in six months since criminalisation